Therapeutic Antibodies in Cancer Treatment in the UK

The growing understanding of the molecular mechanisms of carcinogenesis accelerated the development of monoclonal therapeutic antibodies to specifically target multiple cancer pathways. Recombinant protein therapeutics now constitute a large proportion of yearly approved medicines. Oncology, autoimm...

Descripción completa

Detalles Bibliográficos
Autores principales: Eltarhoni, Khadiga, Kamel, Faddy, Ihebunezie, Katrina, Nisar, Pasha, Soloviev, Mikhail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739895/
https://www.ncbi.nlm.nih.gov/pubmed/36498915
http://dx.doi.org/10.3390/ijms232314589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739895/
https://www.ncbi.nlm.nih.gov/pubmed/36498915
http://dx.doi.org/10.3390/ijms232314589

Ejemplares similares